HEADER LIGASE 19-APR-01 1IHO TITLE CRYSTAL APO-STRUCTURE OF PANTOTHENATE SYNTHETASE FROM E. COLI COMPND MOL_ID: 1; COMPND 2 MOLECULE: PANTOATE--BETA-ALANINE LIGASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PANTOTHENATE SYNTHETASE, PANTOATE ACTIVATING ENZYME; COMPND 5 EC: 6.3.2.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 GENE: PANC; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: AT1371; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PUC19 PCL KEYWDS ROSSMANN FOLD, DIMER, APO, HIGH, KSMKS, FLEXIBLE DOMAINS, KEYWDS 2 MULTIDOMAIN, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR F.VON DELFT,A.LEWENDON,V.DHANARAJ,T.L.BLUNDELL,C.ABELL,A.SMITH REVDAT 5 24-JUL-19 1IHO 1 REMARK REVDAT 4 04-OCT-17 1IHO 1 REMARK REVDAT 3 12-NOV-14 1IHO 1 KEYWDS REVDAT 2 24-FEB-09 1IHO 1 VERSN REVDAT 1 30-MAY-01 1IHO 0 JRNL AUTH F.VON DELFT,A.LEWENDON,V.DHANARAJ,T.L.BLUNDELL,C.ABELL, JRNL AUTH 2 A.G.SMITH JRNL TITL THE CRYSTAL STRUCTURE OF E. COLI PANTOTHENATE SYNTHETASE JRNL TITL 2 CONFIRMS IT AS A MEMBER OF THE CYTIDYLYLTRANSFERASE JRNL TITL 3 SUPERFAMILY. JRNL REF STRUCTURE V. 9 439 2001 JRNL REFN ISSN 0969-2126 JRNL PMID 11377204 JRNL DOI 10.1016/S0969-2126(01)00604-9 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.4 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM 5% REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.211 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.211 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 4062 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 77295 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.195 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 6239 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4320 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 16 REMARK 3 SOLVENT ATOMS : 614 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 4956.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 4420.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 2035 REMARK 3 NUMBER OF RESTRAINTS : 1823 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 ANGLE DISTANCES (A) : 0.024 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.023 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.030 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.040 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.010 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.070 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: INITIAL REFINEMENT: REFMAC REMARK 3 COMPLETE MISSING SEGEMENTS: BUSTER/TNT REMARK 3 FINAL REFINEMENT: SHELXL; REMARK 3 REMARK 3 PHASES WERE DERIVED FROM 3 SEMET MAD WAVELENGTHS REMARK 3 COMBINED WITH A NATIVE, AND THEN REFINED IT REMARK 3 AGAINST THE NATIVE, BUT INCLUDING EXPERIMENTAL REMARK 3 PHASES. REMARK 4 REMARK 4 1IHO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-APR-01. REMARK 100 THE DEPOSITION ID IS D_1000013277. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-MAY-99; 30-MAY-99 REMARK 200 TEMPERATURE (KELVIN) : 100; 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : NSLS; NSLS REMARK 200 BEAMLINE : X25; X25 REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 0.970,0.8850,0.9791; 1.1 REMARK 200 MONOCHROMATOR : SI(111); SI(111) REMARK 200 OPTICS : CONDENSING MIRROR TUNABLE REMARK 200 MONOCHROMATOR; CONDENSING MIRROR REMARK 200 TUNABLE MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD REMARK 200 DETECTOR MANUFACTURER : BRANDEIS - B4; BRANDEIS - B4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 81357 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.100 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.10300 REMARK 200 R SYM (I) : 0.10300 REMARK 200 FOR THE DATA SET : 15.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.60000 REMARK 200 R SYM FOR SHELL (I) : 0.60000 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD; NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHARP, SNB, BUSTER, TNT, SHELX REMARK 200 STARTING MODEL: FROM EXPERIMENTAL PHASES REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000 (4-6%), TRIS BUFFER PH 8 (50 REMARK 280 MM), VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.03750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS COMPLETELY REMARK 300 REPRESENTED BY THE DIMER IN THE REMARK 300 ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 283 REMARK 465 ALA B 283 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 64 CZ NH1 NH2 REMARK 470 GLU A 66 CD OE1 OE2 REMARK 470 GLU A 77 CD OE1 OE2 REMARK 470 LYS A 96 CG CD CE NZ REMARK 470 ASP A 223 CG OD1 OD2 REMARK 470 GLU A 235 CD OE1 OE2 REMARK 470 GLU A 253 CD OE1 OE2 REMARK 470 GLU A 256 CB CG CD OE1 OE2 REMARK 470 LYS A 259 CG CD CE NZ REMARK 470 LYS B 45 CE NZ REMARK 470 ARG B 64 CB CG CD NE CZ NH1 NH2 REMARK 470 GLU B 66 CB CG CD OE1 OE2 REMARK 470 ARG B 70 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 80 CG OE1 OE2 REMARK 470 LYS B 84 CG CD CE NZ REMARK 470 LYS B 86 CD CE NZ REMARK 470 LYS B 96 CG CD CE NZ REMARK 470 GLU B 104 CG CD OE1 OE2 REMARK 470 LYS B 181 CG CD CE NZ REMARK 470 ARG B 189 CB CG CD NE CZ NH1 NH2 REMARK 470 TYR B 192 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU B 235 CD OE1 OE2 REMARK 470 GLU B 253 CD OE1 OE2 REMARK 470 GLU B 256 CG CD OE1 OE2 REMARK 470 LYS B 259 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 47 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 ARG A 128 NE - CZ - NH1 ANGL. DEV. = -3.2 DEGREES REMARK 500 ARG A 189 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 ARG B 11 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG B 18 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG B 23 NE - CZ - NH2 ANGL. DEV. = -4.8 DEGREES REMARK 500 ARG B 246 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 86 31.11 71.81 REMARK 500 LEU A 118 -122.18 50.00 REMARK 500 THR B 74 52.11 -142.21 REMARK 500 LEU B 118 -119.93 51.54 REMARK 500 SER B 187 141.97 -173.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRS A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 703 DBREF 1IHO A 1 283 UNP P31663 PANC_ECOLI 1 283 DBREF 1IHO B 1 283 UNP P31663 PANC_ECOLI 1 283 SEQRES 1 A 283 MET LEU ILE ILE GLU THR LEU PRO LEU LEU ARG GLN GLN SEQRES 2 A 283 ILE ARG ARG LEU ARG MET GLU GLY LYS ARG VAL ALA LEU SEQRES 3 A 283 VAL PRO THR MET GLY ASN LEU HIS ASP GLY HIS MET LYS SEQRES 4 A 283 LEU VAL ASP GLU ALA LYS ALA ARG ALA ASP VAL VAL VAL SEQRES 5 A 283 VAL SER ILE PHE VAL ASN PRO MET GLN PHE ASP ARG PRO SEQRES 6 A 283 GLU ASP LEU ALA ARG TYR PRO ARG THR LEU GLN GLU ASP SEQRES 7 A 283 CYS GLU LYS LEU ASN LYS ARG LYS VAL ASP LEU VAL PHE SEQRES 8 A 283 ALA PRO SER VAL LYS GLU ILE TYR PRO ASN GLY THR GLU SEQRES 9 A 283 THR HIS THR TYR VAL ASP VAL PRO GLY LEU SER THR MET SEQRES 10 A 283 LEU GLU GLY ALA SER ARG PRO GLY HIS PHE ARG GLY VAL SEQRES 11 A 283 SER THR ILE VAL SER LYS LEU PHE ASN LEU VAL GLN PRO SEQRES 12 A 283 ASP ILE ALA CYS PHE GLY GLU LYS ASP PHE GLN GLN LEU SEQRES 13 A 283 ALA LEU ILE ARG LYS MET VAL ALA ASP MET GLY PHE ASP SEQRES 14 A 283 ILE GLU ILE VAL GLY VAL PRO ILE MET ARG ALA LYS ASP SEQRES 15 A 283 GLY LEU ALA LEU SER SER ARG ASN GLY TYR LEU THR ALA SEQRES 16 A 283 GLU GLN ARG LYS ILE ALA PRO GLY LEU TYR LYS VAL LEU SEQRES 17 A 283 SER SER ILE ALA ASP LYS LEU GLN ALA GLY GLU ARG ASP SEQRES 18 A 283 LEU ASP GLU ILE ILE THR ILE ALA GLY GLN GLU LEU ASN SEQRES 19 A 283 GLU LYS GLY PHE ARG ALA ASP ASP ILE GLN ILE ARG ASP SEQRES 20 A 283 ALA ASP THR LEU LEU GLU VAL SER GLU THR SER LYS ARG SEQRES 21 A 283 ALA VAL ILE LEU VAL ALA ALA TRP LEU GLY ASP ALA ARG SEQRES 22 A 283 LEU ILE ASP ASN LYS MET VAL GLU LEU ALA SEQRES 1 B 283 MET LEU ILE ILE GLU THR LEU PRO LEU LEU ARG GLN GLN SEQRES 2 B 283 ILE ARG ARG LEU ARG MET GLU GLY LYS ARG VAL ALA LEU SEQRES 3 B 283 VAL PRO THR MET GLY ASN LEU HIS ASP GLY HIS MET LYS SEQRES 4 B 283 LEU VAL ASP GLU ALA LYS ALA ARG ALA ASP VAL VAL VAL SEQRES 5 B 283 VAL SER ILE PHE VAL ASN PRO MET GLN PHE ASP ARG PRO SEQRES 6 B 283 GLU ASP LEU ALA ARG TYR PRO ARG THR LEU GLN GLU ASP SEQRES 7 B 283 CYS GLU LYS LEU ASN LYS ARG LYS VAL ASP LEU VAL PHE SEQRES 8 B 283 ALA PRO SER VAL LYS GLU ILE TYR PRO ASN GLY THR GLU SEQRES 9 B 283 THR HIS THR TYR VAL ASP VAL PRO GLY LEU SER THR MET SEQRES 10 B 283 LEU GLU GLY ALA SER ARG PRO GLY HIS PHE ARG GLY VAL SEQRES 11 B 283 SER THR ILE VAL SER LYS LEU PHE ASN LEU VAL GLN PRO SEQRES 12 B 283 ASP ILE ALA CYS PHE GLY GLU LYS ASP PHE GLN GLN LEU SEQRES 13 B 283 ALA LEU ILE ARG LYS MET VAL ALA ASP MET GLY PHE ASP SEQRES 14 B 283 ILE GLU ILE VAL GLY VAL PRO ILE MET ARG ALA LYS ASP SEQRES 15 B 283 GLY LEU ALA LEU SER SER ARG ASN GLY TYR LEU THR ALA SEQRES 16 B 283 GLU GLN ARG LYS ILE ALA PRO GLY LEU TYR LYS VAL LEU SEQRES 17 B 283 SER SER ILE ALA ASP LYS LEU GLN ALA GLY GLU ARG ASP SEQRES 18 B 283 LEU ASP GLU ILE ILE THR ILE ALA GLY GLN GLU LEU ASN SEQRES 19 B 283 GLU LYS GLY PHE ARG ALA ASP ASP ILE GLN ILE ARG ASP SEQRES 20 B 283 ALA ASP THR LEU LEU GLU VAL SER GLU THR SER LYS ARG SEQRES 21 B 283 ALA VAL ILE LEU VAL ALA ALA TRP LEU GLY ASP ALA ARG SEQRES 22 B 283 LEU ILE ASP ASN LYS MET VAL GLU LEU ALA HET TRS A 701 8 HET EDO A 702 6 HET EDO B 703 6 HETNAM TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL HETNAM EDO 1,2-ETHANEDIOL HETSYN TRS TRIS BUFFER HETSYN EDO ETHYLENE GLYCOL FORMUL 3 TRS C4 H12 N O3 1+ FORMUL 4 EDO 2(C2 H6 O2) FORMUL 6 HOH *614(H2 O) HELIX 1 1 THR A 6 GLU A 20 1 15 HELIX 2 2 HIS A 34 ALA A 48 1 15 HELIX 3 3 ASN A 58 PHE A 62 5 5 HELIX 4 4 ARG A 64 TYR A 71 1 8 HELIX 5 5 THR A 74 ARG A 85 1 12 HELIX 6 6 SER A 94 TYR A 99 1 6 HELIX 7 7 GLY A 113 MET A 117 5 5 HELIX 8 8 LEU A 118 ARG A 123 1 6 HELIX 9 9 GLY A 125 GLN A 142 1 18 HELIX 10 10 ASP A 152 GLY A 167 1 16 HELIX 11 11 SER A 187 LEU A 193 5 7 HELIX 12 12 THR A 194 ALA A 201 1 8 HELIX 13 13 PRO A 202 ALA A 217 1 16 HELIX 14 14 ASP A 221 GLY A 237 1 17 HELIX 15 15 THR B 6 GLY B 21 1 16 HELIX 16 16 HIS B 34 ALA B 48 1 15 HELIX 17 17 ASN B 58 PHE B 62 5 5 HELIX 18 18 ARG B 64 ARG B 70 1 7 HELIX 19 19 THR B 74 ARG B 85 1 12 HELIX 20 20 SER B 94 TYR B 99 1 6 HELIX 21 21 LEU B 118 ARG B 123 1 6 HELIX 22 22 GLY B 125 GLN B 142 1 18 HELIX 23 23 ASP B 152 GLY B 167 1 16 HELIX 24 24 SER B 187 LEU B 193 5 7 HELIX 25 25 THR B 194 ALA B 201 1 8 HELIX 26 26 PRO B 202 GLY B 218 1 17 HELIX 27 27 ASP B 221 GLY B 237 1 17 SHEET 1 A 6 LEU A 2 ILE A 4 0 SHEET 2 A 6 LEU A 89 PHE A 91 1 O VAL A 90 N ILE A 4 SHEET 3 A 6 VAL A 50 ILE A 55 1 O VAL A 51 N LEU A 89 SHEET 4 A 6 VAL A 24 THR A 29 1 O ALA A 25 N VAL A 52 SHEET 5 A 6 ILE A 145 GLY A 149 1 O ILE A 145 N LEU A 26 SHEET 6 A 6 GLU A 171 VAL A 175 1 O GLU A 171 N ALA A 146 SHEET 1 B 2 TYR A 108 ASP A 110 0 SHEET 2 B 2 TYR B 108 ASP B 110 -1 O TYR B 108 N ASP A 110 SHEET 1 C 3 ARG A 239 ASP A 247 0 SHEET 2 C 3 ARG A 260 LEU A 269 -1 N VAL A 262 O ARG A 246 SHEET 3 C 3 ALA A 272 GLU A 281 -1 O ALA A 272 N LEU A 269 SHEET 1 D 6 LEU B 2 ILE B 4 0 SHEET 2 D 6 LEU B 89 PHE B 91 1 N VAL B 90 O LEU B 2 SHEET 3 D 6 VAL B 50 ILE B 55 1 O VAL B 51 N LEU B 89 SHEET 4 D 6 VAL B 24 THR B 29 1 O ALA B 25 N VAL B 52 SHEET 5 D 6 ILE B 145 GLY B 149 1 O ILE B 145 N LEU B 26 SHEET 6 D 6 GLU B 171 VAL B 175 1 O GLU B 171 N ALA B 146 SHEET 1 E 3 ARG B 239 ASP B 247 0 SHEET 2 E 3 ARG B 260 LEU B 269 -1 N VAL B 262 O ARG B 246 SHEET 3 E 3 ALA B 272 GLU B 281 -1 O ALA B 272 N LEU B 269 SITE 1 AC1 3 SER A 187 ASN A 190 ARG A 198 SITE 1 AC2 5 MET A 30 GLN A 61 ILE A 133 GLN A 155 SITE 2 AC2 5 HOH A 709 SITE 1 AC3 6 MET B 30 GLN B 61 ILE B 133 GLN B 155 SITE 2 AC3 6 HOH B 741 HOH B 825 CRYST1 66.031 78.075 77.126 90.00 103.71 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015144 0.000000 0.003695 0.00000 SCALE2 0.000000 0.012808 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013346 0.00000 MASTER 279 0 3 27 20 0 5 6 0 0 0 44 END